Tolerance in clinical transplantation: Progress, challenge or just a dream?

Langenbeck's Archives of Surgery

Volumn 396, Issue 4, 2011, Pages 475-487

  Fändrich, Fred ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Clinical operational tolerance; Immune regulation; Organ tolerance; Regulatory cell; Solid organ transplantation; Stem cell; Tolerance

Indexed keywords

CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; GIVINOSTAT; IMMUNOSUPPRESSIVE AGENT; LF 15 0195; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; CARDIOVASCULAR DISEASE; CHRONIC GRAFT REJECTION; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; DRUG FATALITY; FEASIBILITY STUDY; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MICROARRAY ANALYSIS; MORTALITY; ORGAN TRANSPLANTATION; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL;

GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; ORGAN TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

EID: 79956196136     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-011-0757-z     Document Type: Conference Paper

References (116)

1. HU Meier-Kriesche JD Schold TR Srinivas B Kaplan 2004 Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era Am J Transplant 4 3 378 383 14961990 (Pubitemid 38282293)
2. J Lerut E Bonaccorsi-Riani P Finet P Gianello 2009 Minimization of steroids in liver transplantation Transpl Int 22 1 2 19 19121145
3. AJ Demetris JG Lunz P Randhawa T Wu M Nalesnik AW Thomson 2009 Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective Transpl Int 22 1 120 141 18980624
4. G Orlando S Soker K Wood 2009 Operational tolerance after liver transplantation J Hepatol 50 6 1247 1257 19394103
5. G Orlando P Hematti RJ Stratta GW Burke P Di Cocco F Pisani S Soker K Wood 2010 Clinical operational tolerance after renal transplantation current status and future challenges Ann Surg 252 6 915 928 21107102
6. UG Svendsen S Aggestrup C Heilmann N Jacobsen C Koch B Larsen A Svejgaard B Thisted G Petterson 1995 Transplantation of a lobe of lung from mother-to-child following previous transplantation with maternal bone-marrow Eur Respir J 8 2 334 337 7758573 1:STN:280:DyaK2M3nvVegsA%3D%3D
7. GD Comerci TM Williams S Kellie 2009 Immune tolerance after total lymphoid irradiation for heart transplantation: immunosuppressant-free survival for 8 years J Heart Lung Transplant 28 7 743 745 19560706
8. R Weil TE Starzl KA Porter M Kershaw GPJ Schroter LJ Koep 1980 Renal isotransplantation without immunosuppression Ann Surg 192 1 108 110 6996622 (Pubitemid 10083269)
9. WJ Burlingham AP Grailer JH Fechner S Kusaka M Trucco M Kocova FO Belzer HW Sollinger 1995 Microchimerism linked to cytotoxic T-lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal-transplant recipient Transplantation 59 8 1147 1155 7732562 1:STN:280:DyaK2M3ltVWluw%3D%3D
10. HL Trivedi VV Mishra AV Vanikar PR Modi VR Shah PR Shah A Firoz 2006 Embryonic stem cell derived and adult hematopoietic stem cell transplantation for tolerance induction in a renal allograft recipient: a case report Transplant Proc 38 9 3103 3108 17112910 1:STN:280:DC%2BD28nnslWntA%3D%3D (Pubitemid 44737971)
11. GW Burke G Ciancio R Cirocco M Markou D Coker D Roth J Nery V Esquenazi J Miller 1996 Association of interleukin-10 with rejection-sparing effect in septic kidney transplant recipients Transplantation 61 7 1114 1116 8623196 1:STN:280:DyaK283is1WgsQ%3D%3D (Pubitemid 26120265)
12. ML Owens JG Maxwell J Goodnight MW Wolcott 1975 Discontinuance of immunosuppression in renal-transplant patients Arch Surg 110 12 1450 1451 1106353 1:STN:280:DyaE28%2FoslWgtA%3D%3D
13. KM Zoller SI Cho JJ Cohen JT Harrington 1980 Cessation of immunosuppressive therapy after successful transplantation-a national survey Kid Int 18 1 110 114 1:STN:280:DyaL3M7ntFWmuw%3D%3D (Pubitemid 10044821)
14. AM VanBuskirk WJ Burlingham E Jankowska-Gan T Chin S Kusaka F Geissler RP Pelletier CG Orosz 2000 Human allograft acceptance is associated with immune regulation J Clin Invest 106 1 145 155 10880058 1:CAS:528:DC%2BD3cXks1yrsL0%3D (Pubitemid 30437250)
15. Q Xu J Lee E Jankowska-Gan J Schultz DA Roennburg LD Haynes S Kusaka HW Sollinger SJ Knechtle AM VanBuskirk Jr.Torrealba WJ Burlingham 2007 Human CD4(+)CD25(low) adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. (vol 178, pg 3983, 2007) J Immunol 178 11 7488 (Pubitemid 46847482)
16. G Roussey-Kesler M Giral A Moreau JF Subra C Legendre C Noel E Pillebout S Brouard JP Soulillou 2006 Clinical operational tolerance after kidney transplantation Am J Transplant 6 4 736 746 16539630 1:STN:280: DC%2BD287ns1yluw%3D%3D (Pubitemid 43345011)
17. D Baeten S Louis C Braud C Braudeau C Ballet F Moizant A Pallier M Giral S Brouard JP Soulillou 2006 Phenotypically and functionally distinct CD8(+) lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients J Am Soc Nephrol 17 1 294 304 16338967 1:CAS:528:DC%2BD28XhtF2jsro%3D
18. S Brouard E Mansfield C Braud L Li M Giral SC Hsieh D Baeten M Zhang J Ashton-Chess C Braudeau F Hsieh A Dupont A Pallier A Moreau S Louis C Ruiz O Salvatierra JP Soulillou M Sarwal 2007 Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance Proc Natl Acad Sci USA 104 39 15448 15453 17873064 1:CAS:528:DC%2BD2sXhtFWqtLrM (Pubitemid 47502937)
19. WJ Burlingham E Jankowska-Gan A VanBuskirk CG Orosz JH Lee S Kusaka 2000 Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis Hum Immunol 61 12 1395 1402 11163098 1:CAS:528:DC%2BD3MXksVWnsw%3D%3D (Pubitemid 32102430)
20. RE Billingham L Brent PB Medawar 1953 Actively acquired tolerance of foreign cells Nature 172 4379 603 606 13099277 1:STN:280:DyaG2c%2FitVSqsg%3D%3D
21. GV Mazariegos J Reyes IR Marino AJ Demetris B Flynn W Irish J McMichael JJ Fung TE Starzl 1997 Weaning of immunosuppression in liver transplant recipients Transplantation 63 2 243 249 9020325 1:STN:280:DyaK2s7nt1answ%3D%3D (Pubitemid 27121206)
22. N Assy PC Adams P Myers V Simon GY Minuk W Wall CN Ghent 2007 Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid Transplantation 83 12 1571 1576 17589339 1:CAS:528:DC%2BD2sXmslynsrk%3D (Pubitemid 46987908)
23. J Devlin D Doherty L Thomson T Wong P Donaldson B Portmann R Williams 1998 Defining the outcome of immunosuppression withdrawal after liver transplantation Hepatology 27 4 926 933 9537430 1:STN:280:DyaK1c7ps1OktQ%3D%3D (Pubitemid 28160476)
24. JD Eason AJ Cohen S Nair T Alcantera GE Loss 2005 Tolerance: is it worth the risk? Transplantation 79 9 1157 1159 15880061 (Pubitemid 40664015)
25. R Girlanda M Rela R Williams JG O'Grady ND Heaton 2005 Long-term outcome of immunosuppression withdrawal after liver transplantation Transplant Proc 37 4 1708 1709 15919439 1:CAS:528:DC%2BD2MXks1Crsrs%3D (Pubitemid 40790804)
26. JA Pons J Yelamos P Ramirez M Oliver-Bonet A Sanchez M Rodriguez-Gago J Navarro J Bermejo R Robles P Parrilla 2003 Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression Transplantation 75 7 1045 1047 12698096 (Pubitemid 36438536)
27. M Takatsuki S Uemoto Y Inomata S Sakamoto M Hayashi M Ueda T Kanematsu K Tanaka 2001 Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance Transpl Immunol 8 4 279 286 11316071 1:CAS:528:DC%2BD3MXjsFeqsb8%3D (Pubitemid 32249016)
28. G Tisone G Orlando A Cardillo G Palmieri TM Manzia L Baiocchi R Lionetti A Anselmo L Toti M Angelico 2006 Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence J Hepatol 44 4 702 709 16473433 1:CAS:528:DC%2BD28XisFyqt7c%3D
29. P Tryphonopoulos AG Tzakis D Weppler R Garcia-Morales T Kato Jr.Madariaga DM Levi S Nishida J Moon G Selvaggi A Regev C Nery P Bejarano A Khaled G Kleiner V Esquenazi J Miller P Ruiz C Ricordi 2005 The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation Am J Transplant 5 3 608 613 15707417 (Pubitemid 40313354)
30. S Feng U Ekong S Lobritto A Demetris P Rosenthal E Alonso N Tchao 2009 ITN029ST: immunosuppression withdrawal in pediatric recipients of parental living donor liver transplants: preliminary results of a pilot study Am J Transplant 9 244 245
31. C Benitez JJ Lozano M Martinez-Llordella I Puig-Pey M Lopez A Rodriguez G Tisone J Pirenne J Lerut A Sanchez-Fueyo 2009 Use of transcriptional biomarkers to identify liver transplant recipients who can successfully discontinue immunosuppressive therapy Am J Transplant 9 252
32. J Lerut A Sanchez-Fueyo 2006 An appraisal of tolerance in liver transplantation Am J Transplant 6 8 1774 1780 16889539 1:STN:280: DC%2BD28vms1aisg%3D%3D (Pubitemid 44024949)
33. TE Starzl N Murase K Abu-Elmagd EA Gray R Shapiro B Eghtesad RJ Corry ML Jordan P Fontes T Gayowski G Bond VP Scantlebury S Potdar P Randhawa T Wu A Zeevi MA Nalesnik J Woodward A Marcos M Trucco AJ Demetris JJ Fung 2003 Tolerogenic immunosuppression for organ transplantation Lancet 361 9368 1502 1510 12737859 (Pubitemid 36566340)
34. R Calne P Friend S Moffatt A Bradley G Hale J Firth J Bradley K Smith H Waldmann 1998 Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients Lancet 351 9117 1701 1702 9734890 1:STN:280:DyaK1cvgtl2muw%3D%3D (Pubitemid 28254534)
35. AD Kirk RB Mannon DE Kleiner JS Swanson RL Kampen LK Cendales EA Elster T Wakefield C Chamberlain SC Hoffmann DA Hale 2005 Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin Transplantation 80 8 1051 1059 16278585 1:CAS:528:DC%2BD2MXhtF2gu7fK (Pubitemid 41611927)
36. P Trzonkowski M Zilvetti S Chapman J Wieckiewicz A Sutherland P Friend KJ Wood 2008 Homeostatic repopulation by CD28(-)CD8(+) T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression Am J Transplant 8 2 338 347 18211507 1:CAS:528: DC%2BD1cXisFGitrk%3D
37. MR Clatworthy PJ Friend RY Calne PRU Rebello G Hale H Waldmann CJE Watson 2009 Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up Transplantation 87 7 1092 1095 19352132 1:CAS:528:DC%2BD1MXktFCmu7Y%3D
38. G Ciancio GW Burke 2008 Alemtuzumab (Campath-1H) in kidney transplantation Am J Transplant 8 1 15 20 18093269 1:CAS:528: DC%2BD1cXhslymtrg%3D
39. ZH Wu SJ Bensinger JD Zhang CQ Chen XL Yuan XL Huang JF Markmann A Kassaee BR Rosengard WW Hancock MH Sayegh LA Turka 2004 Homeostatic proliferation is a barrier to transplantation tolerance Nat Med 10 1 87 92 14647496 1:CAS:528:DC%2BD2cXlsFCn (Pubitemid 38524703)
40. MH Sayegh NA Fine JL Smith HG Rennke EL Milford NL Tilney 1991 Immunological-tolerance to renal-allografts after bone-marrow transplants from the same donors Ann Int Med 114 11 954 955 2024863 1:STN:280: DyaK3M3itFCiuw%3D%3D
41. B Ernst DS Lee JM Chang J Sprent CD Surh 1999 The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery Immunity 11 2 173 181 10485652 1:CAS:528:DyaK1MXlvVSgsL4%3D (Pubitemid 29428810)
42. AW Goldrath MJ Bevan 1999 Low-affinity ligands for the TCR drive proliferation of mature CD8(+) T cells in lymphopenic hosts Immunity 11 2 183 190 10485653 1:CAS:528:DyaK1MXlvVSgsLw%3D (Pubitemid 29428811)
43. JP Pearl J Parris DA Hale SC Hoffmann WB Bernstein KL Mccoy SJ Swanson RB Mannon M Roederer AD Kirk 2005 Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion Am J Transplant 5 3 465 474 15707400 1:CAS:528:DC%2BD2MXivFSisb0%3D (Pubitemid 40313337)
44. P Trzonkowski M Zilvetti P Friend KJ Wood 2006 Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression Transplantation 82 10 1342 1351 17130784 (Pubitemid 44834311)
45. C Helg B Chapuis JF Bolle P Morel D Salomon E Roux V Antonioli M Jeannet M Leski 1994 Renal-transplantation without immunosuppression in a host with tolerance induced by allogeneic bone-marrow transplantation Transplantation 58 12 1420 1422 7809937 1:STN:280:DyaK2M7gvVyqtw%3D%3D
46. N Jacobsen E Taaning J Ladefoged JK Kristensen FK Pedersen 1994 Tolerance to an Hla-B, Dr disparate kidney allograft after bone-marrow transplantation from same donor Lancet 343 8900 800 7907762 1:STN:280:DyaK2c7otVOjtw%3D%3D (Pubitemid 24098720)
47. JA Butcher S Hariharan MB Adams CP Johnson AM Roza EP Cohen 1999 Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression Clin Transplant 13 4 330 335 10485375 1:STN:280:DyaK1Mvhtlertw%3D%3D (Pubitemid 29392624)
48. JM Sorof MA Koerper AA Portale D Potter K Desantes M Cowan 1995 Renal-transplantation without chronic immunosuppression after T-cell-depleted, Hla-mismatched bone-marrow transplantation Transplantation 59 11 1633 1635 7778182 1:STN:280:DyaK2M3pslSnsw%3D%3D
49. MT Sellers MH Deierhoi JJ Curtis RS Gaston BA Julian DC Lanier AG Diethelm 2001 Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up Transplantation 71 11 1681 1683 11435983 1:STN:280:DC%2BD3MznslKltg%3D%3D (Pubitemid 32574173)
50. LH Buhler TR Spitzer M Sykes DH Sachs FL Delmonico N Tolkoff-Rubin SL Saidman R Sackstein S McAfee B Dey C Colby AB Cosimi 2002 Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease Transplantation 74 10 1405 1409 12451240
51. T Kawai AB Cosimi TR Spitzer N Tolkoff-Rubin M Suthanthiran SL Saidman J Shaffer FI Preffer RC Ding V Sharma JA Fishman B Dey DSC Ko M Hertl NB Goes WC Wong WW Williams RB Colvin M Sykes DH Sachs 2008 Brief report: HLA-mismatched renal transplantation without maintenance immunosuppression N Engl J Med 358 4 353 361 18216355 1:CAS:528:DC%2BD1cXhtFCjsrg%3D (Pubitemid 351159234)
52. F Porcheray W Wong SL Saidman J De Vito TC Girouard M Chittenden J Shaffer N Tolkoff-Rubin BR Dey TR Spitzer RB Colvin AB Cosimi T Kawai DH Sachs M Sykes E Zorn 2009 B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans Am J Transplant 9 9 2126 2135 19624570 1:CAS:528:DC%2BD1MXht1ansrnF
53. D Bloom Z Chang K Pauly J Kwun J Fechner C Hayes M Samaniego S Knechtle 2009 BAFF is increased in renal transplant patients following treatment with alemtuzumab Am J Transplant 9 8 1835 1845 19522878 1:CAS:528:DC%2BD1MXhtVGrur3P
54. TLT Millan JA Shizuru P Hoffmann S Dejbakhsh-Jones JD Scandling FC Grumet JC Tan O Salvatierra RT Hoppe S Strober 2002 Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation Transplantation 73 9 1386 1391 12023614 (Pubitemid 34547457)
55. JD Scandling S Busque S Dejbakhsh-Jones C Benike MT Millan JA Shizuru RT Hoppe R Lowsky EG Engleman S Strober 2008 Brief report: tolerance and chimerism after renal and hematopoietic-cell transplantation N Engl J Med 358 4 362 368 18216356 1:CAS:528:DC%2BD1cXhtFShs7o%3D (Pubitemid 351159235)
56. RD Owen 1945 Immunogenetic consequences of vascular anastomoses between bovine twins Science 102 2651 400 401 17755278 1:STN:280:DC%2BC3czotFWiug%3D%3D
57. WT Newton CB Anderson 1973 Planned preimmunization of renal-allograft recipients Surgery 74 3 430 436 4269174 1:STN:280:DyaE3s3ivFOgtw%3D%3D
58. WJ Burlingham 1996 Chimerism after organ transplantation: is there any clinical significance? Clin Transplant 10 1 110 117 8680046 1:STN:280: DyaK283lt1SksA%3D%3D (Pubitemid 26076440)
59. A Schiopu KJ Wood 2008 Regulatory T cells: hypes and limitations Curr Opin Organ Transplant 13 4 333 338 18685326
60. P Sagoo G Lombardi RI Lechler 2008 Regulatory T cells as therapeutic cells Curr Opin Organ Transplant 13 6 645 653 19060557
61. A Demirkiran A Kok J Kwekkeboom JG Kusters HJ Metselaar HW Tilanus LJW van der Laan 2006 Low circulating regulatory T-cell levels after acute rejection in liver transplantation Liver Transplant 12 2 277 284 (Pubitemid 43273788)
62. O Bestard JM Cruzado I Rama J Torras M Goma D Seron F Moreso S Gil-Vernet JM Grinyo 2008 Presence of FoxP3(+) regulatory T cells predicts outcome of subclinical rejection of renal allografts J Am Soc Nephrol 119 10 2020 2026
63. F Meloni P Vitulo AM Bunco E Paschetto M Morosini A Cascina I Mazzucchelli L Ciardelli T Ogglonni AM Fietta E Pozzi M Vigano 2004 Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome Transplantation 77 5 762 766 15021844 (Pubitemid 38366987)
64. S Radhakrishnan R Cabrera EL Schenk P Nava-Parada MP Bell VP Van Keulen RJ Marler SJ Felts LR Pease 2010 Reprogrammed FoxP3(+) T regulatory cells become IL-17(+) antigen-specific autoimmune effectors in vitro and in vivo (Retraction of vol 181, pg 3137, 2008) J Immunol 184 11 6556
65. B Afzali P Mitchell RI Lechler S John G Lombardi 2010 Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells Clin Exp Immunol 159 2 120 130 19912251 1:CAS:528: DC%2BC3cXhslOis74%3D
66. HJPM Koenen RL Smeets PM Vink E van Rijssen AMH Boots I Joosten 2008 Human CD25(high)Foxp3(pos) regulatory T cells differentiate into IL-17-producing cells Blood 112 6 2340 2352 18617638 1:CAS:528:DC%2BD1cXhtFCrurbF
67. J Wang TWJ Huizinga REM Toes 2009 De novo generation and enhanced suppression of human CD4(+)CD25(+) regulatory T cells by retinoic acid J Immunol 183 6 4119 4126 19717521 1:CAS:528:DC%2BD1MXhtVOmu7rJ
68. P Mitchell B Afzali G Lombardi RI Lechler 2009 The T helper 17-regulatory T cell axis in transplant rejection and tolerance Curr Opin Organ Transplant 14 4 326 331 19448538
69. SE Hanson ML Bentz P Hematti 2010 Mesenchymal stem cell therapy for nonhealing cutaneous wounds Plast Reconstr Surg 125 2 510 516 20124836 1:CAS:528:DC%2BC3cXitlajsrk%3D
70. K Le Blanc I Rasmusson B Sundberg C Gotherstrom M Hassan M Uzunel O Ringden 2004 Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells Lancet 363 9419 1439 1441 15121408 (Pubitemid 38586721)
71. K Le Blanc O Ringden 2007 Immunomodulation by mesenchymal stem cells and clinical experience J Int Med 262 5 509 525 (Pubitemid 47620502)
72. K Le Blanc MF Pittenger 2005 Mesenchymal stem cells: progress toward promise Cytotherapy 7 1 36 45 16040382 (Pubitemid 40542402)
73. M Crop C Baan W Weimar M Hoogduijn 2009 Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation Transpl Int 22 4 365 376 19000235 1:CAS:528:DC%2BD1MXkvVWnu78%3D
74. B Pulendran 2009 Modulating vaccine responses with innate immunity Cytokine 48 1-2 5
75. RM Steinman D Hawiger MC Nussenzweig 2003 Tolerogenic dendritic cells Ann Rev of Immunol 21 685 711 1:CAS:528:DC%2BD3sXjtF2is7g%3D (Pubitemid 37174545)
76. Y Onishi Z Fehervari T Yamaguchi S Sakaguchi 2008 Foxp3(+) natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation Proc Natl Acad Sci USA 105 29 10113 10118 18635688 1:CAS:528:DC%2BD1cXptFOhurw%3D
77. K Wing Y Onishi P Prieto-Martin T Yamaguchi M Miyara Z Fehervari T Nomura S Sakaguchi 2008 CTLA-4 control over Foxp3(+) regulatory T cell function Science 322 5899 271 275 18845758 1:CAS:528:DC%2BD1cXht1Slu7%2FJ
78. S Manicassamy B Reizis R Ravindran H Nakaya RM Salazar-Gonzalez YC Wang B Pulendran 2010 Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine Science 329 5993 849 853 20705860 1:CAS:528:DC%2BC3cXpvV2hsr8%3D
79. W Reichardt C Durr D von Elverfeldt E Juttner UV Gerlach M Yamada B Smith RS Negrin R Zeiser 2008 Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation J Immunol 181 7 4770 4779 18802080 1:CAS:528:DC%2BD1cXhtFarurvP
80. AM Stax KA Gelderman N Schlagwein MC Essers SWA Kamerling AM Woltman C van Kooten 2008 Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models Transplantation 86 9 1275 1282 19005410 1:CAS:528:DC%2BD1cXhtlKis7%2FJ
81. XS Zhang M Li DM Lian XF Zheng ZX Zhang TE Ichim XP Xia XY Huang C Vladau M Suzuki B Garcia AM Jevnikar WP Min 2008 Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection Clin Immunol 127 3 313 321 18358783 1:CAS:528:DC%2BD1cXmt12ru7k%3D
82. P Reddy YP Sun T Toubai R Duran-Struuck SG Clouthier E Weisiger Y Maeda I Tawara O Krijanovski E Gatza C Liu C Malter P Mascagni CA Dinarello JLM Ferrara 2008 Histone deacetylase inhibition modulates indoleamine 2, 3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice J Clin Invest 118 7 2562 2573 18568076 1:CAS:528:DC%2BD1cXot1Ontbs%3D (Pubitemid 351949783)
83. BG Brem-Exner C Sattler JA Hutchinson GE Koehl K Kronenberg S Farkas S Inoue C Blank SJ Knechtle HJ Schlitt F Fandrich EK Geissler 2008 Macrophages driven to a novel state of activation have anti-inflammatory properties in mice J Immunol 180 1 335 349 18097035 1:CAS:528:DC%2BD2sXhsVGjtbfO
84. F Fandrich XB Lin GX Chai M Schulze D Ganten M Bader J Holle DS Huang R Parwaresch N Zavazava B Binas 2002 Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning Nat Med 8 2 171 178 11821902 1:CAS:528:DC%2BD38Xht1equ7o%3D (Pubitemid 34155129)
85. JA Hutchinson P Riquelme BG Brem-Exner M Schulze M Matthai L Renders U Kunzendorf EK Geissler F Fandrich 2008 Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation Transpl Int 21 8 728 741 18573142
86. JA Hutchinson BG Brem-Exner P Riquelme D Roelen M Schulze K Ivens B Grabensee O Witzke T Philipp L Renders A Humpe A Sotnikova M Matthai A Heumann F Govert T Schulte D Kabelitz FHJ Claas EK Geissler U Kunzendorf F Fandrich 2008 A cell-based approach to the minimization of immunosuppression in renal transplantation Transpl Int 21 8 742 754 18573141
87. JA Hutchinson D Roelen P Riquelme BG Brem-Exner O Witzke T Philipp M Matthai F Govert FHJ Claas E Westphal U Kunzendorf EK Geissler F Fandrich 2008 Preoperative treatment of a presensitized kidney transplant recipient with donor-derived transplant acceptance-inducing cells Transpl Int 21 8 808 813 18573140
88. P Riquelme F Govert EK Geissler F Fandrich JA Hutchinson 2009 Human transplant acceptance-inducing cells suppress mitogen-stimulated T cell proliferation Transpl Immunol 21 3 162 165 19345264 1:CAS:528: DC%2BD1MXntVyrtbY%3D
89. JA Hutchinson P Riquelme EK Geissler F Fandrich 2009 Macrophages driven to a novel state of activation have tolerogenic properties in kidney transplant recipients Am J Transplant 9 657 657
90. JA Hutchinson F Govert P Riquelme JH Brasen BG Brem-Exner M Matthai M Schulze L Renders U Kunzendorf EK Geissler F Fandrich 2009 Administration of donor-derived transplant acceptance-inducing cells to the recipients of renal transplants from deceased donors is technically feasible Clin Transplant 23 1 140 145 19200227
91. A Castellaneta AW Thomson N Nayyar M de Vera GV Mazariegos 2010 Monitoring the operationally tolerant liver allograft recipient Curr Opin Organ Transplant 15 1 28 34 19890211
92. M Martinez-Llordella JJ Lozano I Puig-Pey G Orlando G Tisone J Lerut C Benitez JA Pons P Parrilla P Ramirez M Bruguera A Rimola A Sanchez-Fueyo 2008 Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients J Clin Invest 118 8 2845 2857 18654667 1:CAS:528:DC%2BD1cXpsVOktbg%3D
93. FD Batista D Iber MS Neuberger 2001 B cells acquire antigen from target cells after synapse formation Nature 411 6836 489 494 11373683 1:CAS:528:DC%2BD3MXkt1ejt7k%3D (Pubitemid 32494396)
94. FE Lund TD Randall 2010 Effector and regulatory B cells: modulators of CD4(+) T cell immunity Nat Rev Immunol 10 4 236 247 20224569 1:CAS:528:DC%2BC3cXjtFSmtbg%3D
95. V Pistoia 1997 Production of cytokines by human B cells in health and disease Immunol Today 18 7 343 350 9238838 1:CAS:528:DyaK2sXks1als7c%3D (Pubitemid 27314471)
96. DP Harris L Haynes PC Sayles DK Duso SM Eaton NM Lepak LL Johnson SL Swain FE Lund 2000 Reciprocal regulation of polarized cytokine production by effector B and T cells Nat Immunol 1 6 475 482 11101868 1:CAS:528: DC%2BD3cXoslyrurY%3D
97. O Thaunat AC Field JP Dai L Louedec N Patey MF Bloch C Mandet MF Belair P Bruneval O Meilhac B Bellon E Joly JB Michel A Nicoletti 2005 Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response Proc Natl Acad Sci USA 102 41 14723 14728 16192350 1:CAS:528: DC%2BD2MXhtFKjsb%2FO (Pubitemid 41457123)
98. F Aloisi R Pujol-Borrell 2006 Lymphoid neogenesis in chronic inflammatory diseases Nat Rev Immunol 6 3 205 217 16498451 1:CAS:528:DC%2BD28Xhsleltbw%3D (Pubitemid 43290990)
99. T Matsushita M Horikawa Y Iwata TF Tedder 2010 Regulatory B cells (B10 Cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis J Immunol 185 4 2240 2252 20624940 1:CAS:528:DC%2BC3cXpslWnu70%3D
100. MR Clatworthy CJE Watson G Plotnek V Bardsley AN Chaudhry JA Bradley KGC Smith 2009 B-cell-depleting induction therapy and acute cellular rejection N Engl J Med 360 25 2683 2685 19535812 1:CAS:528:DC%2BD1MXntlKqtrg%3D
101. B Sawitzki A Bushell U Steger N Jones K Risch A Siepert M Lehmann I Schmitt-Knosalla K Vogt I Gebuhr K Wood HD Volk 2007 Identification of gene markers for the prediction of allograft rejection or permanent acceptance Am J Transplant 7 5 1091 1102 17456197 1:CAS:528:DC%2BD2sXlvF2nu78%3D (Pubitemid 46643117)
102. VH Karam I Gasquet V Delvart C Hiesse R Dorent C Danet D Samuel B Charpentier I Gandjbakhch H Bismuth D Castaing 2003 Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation Transplantation 76 12 1699 1704 14688519 (Pubitemid 38032417)
103. G Tisone G Orlando M Angelico 2007 Operational tolerance in clinical liver transplantation: emerging developments Transpl Immunol 17 2 108 113 17306741 (Pubitemid 46240887)
104. S Strober RJ Lowsky JA Shizuru JD Scandling MT Millan 2004 Approaches to transplantation tolerance in humans Transplantation 77 6 932 936 15077041 (Pubitemid 38436838)
105. M Takatsuki S Uemoto Y Inomata H Egawa T Kiuchi S Fujita M Hayashi T Kanematsu K Tanaka 2001 Weaning of immunosuppression in living donor liver transplant recipients Transplantation 72 3 449 454 11502975 1:CAS:528: DC%2BD3MXmslyjt7c%3D (Pubitemid 32769631)
106. T Koshiba Y Li M Takemura YL Wu S Sakaguchi N Minato KJ Wood H Haga M Ueda S Uemoto 2007 Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation Transpl Immunol 17 2 94 97 17306739 1:CAS:528:DC%2BD2sXhvVOqs7Y%3D (Pubitemid 46240888)
107. Y Li T Koshiba A Yoshizawa A Ito H Egawa S Sakaguchi N Minato KJ Wood K Tanaka 2004 Analysis of peripheral blood mononuclear cells in operational tolerance after living-donor liver transplantation (LDLT) Am J Transplant 4 445
108. A Yoshizawa A Ito Y Li T Koshiba S Sakaguchi KJ Wood K Tanaka 2005 The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation Transplant Proc 37 1 37 39 15808539 1:CAS:528:DC%2BD2MXivFShs7k%3D (Pubitemid 40459681)
109. JA Pons P Ramirez B Revilla-Nuin D Pascual A Baroja-Mazo R Robles F Sanchez-Bueno L Martinez P Parrilla 2009 Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients Clin Transplant 23 3 329 336 19210687
110. M Yoshitomi T Koshiba H Haga Y Li X Zhao D Cheng A Miyagawa H Sakashita T Tsuruyama H Ohe M Ueda S Okamoto H Egawa K Wood S Sakaguchi T Manabe K Tanaka S Uemoto 2009 Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation Transplantation 87 4 606 614 19307800
111. K Kawamoto A Pahuja BJ Hering P Bansal-Pakala 2010 Transforming growth factor beta 1 (TGF-beta 1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3(+) Tregs Transpl Immunol 23 1-2 28 33 20307666 1:CAS:528:DC%2BC3cXnvVyns7k%3D
112. E Morelon N Lefrancois C Besson J Prevautel M Brunet JL Touraine L Badet F Touraine-Moulin O Thaunat C Malcus 2010 Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine Transpl Immunol 23 1-2 53 58 20406686 1:CAS:528:DC%2BC3cXnvVynsL4%3D
113. AL Ma SJ Qi ZY Wang E Massicotte M Dupuis P Daloze HF Chen 2009 Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice Inter Immunopharmacol 9 5 553 563 1:CAS:528:DC%2BD1MXksVWnsL8%3D
114. SA De Serres MH Sayegh N Najafian 2009 Immunosuppressive drugs and Tregs: a critical evaluation! Clinical J Am Soc Nephrol 4 10 1661 1669
115. DS Segundo E Fabrega M Lopez-Hoyos F Pons 2007 Reduced numbers of blood natural regulatory T cells in stable liver transplant recipients with high levels of calcineurin inhibitors Transplant Proc 39 7 2290 2292 (Pubitemid 47418222)
116. J Alberu EM Urrea 2005 Immunosuppression for kidney transplant recipients: current strategies Rev Invest Clin 57 2 213 224 16524061 1:CAS:528:DC%2BD2MXhtFSntrbJ (Pubitemid 41357762)